Back to Results
First PageMeta Content
Pharmaceutical sciences / Food and Drug Administration / Pharmacy / Medical ethics / United States Public Health Service / Pharmaceutical industry / Electronic health record / Reagan-Udall Foundation / Patient safety / Medicine / Health / Pharmacology


Innovation in Medical Evidence Development and Surveillance (IMEDS) Reagan-Udall Foundation June 6, 2013
Add to Reading List

Document Date: 2013-11-25 08:49:25


Open Document

File Size: 598,51 KB

Share Result on Facebook

Company

Worldwide Safety / Pfizer / Merck / Sentinel / Observational Medical Outcomes Partnership / Data Partners / Established Products Regulatory / Products Regulatory / /

/

Facility

Duke University / /

IndustryTerm

health insurance claims / analytical tools / healthcare / marketed medical products / /

Organization

Duke University / Foundation for the National Institutes of Health / Academic Institute / IMEDS Steering Committee / Reagan-Udall Board / FDA / Center for Drug Evaluation and Research / Center for Biologics Evaluation and Research / Reagan-Udall Foundation / /

Person

A. Cavazzoni / Michael Rosenblatt / Janet Woodcock / Marcus D. Wilson / John S. Santa / Elizabeth B. Andrews / Karen Midthun / Robert M. Califf / Jane Perlmutter / /

Position

Advocate / Vice Chancellor for Clinical and Translational Research / Vice President of Pharmacoepidemiology and Risk Management / Vice-Chair / President / Director / Senior Vice President / Executive Vice President and Chief Medical Officer / Chair / Representative / Director / Health Ratings Center / /

PublishedMedium

Consumer Reports / /

URL

http /

SocialTag